top of page

Inside the Supply Chain: How Pro Pharmaceuticals Group Supports Critical Medicine Access

  • 2 days ago
  • 2 min read

At Pro Pharmaceuticals Group (ProPG), our core mission is helping healthcare providers, clinical partners and patients maintain reliable access to critical, high-quality medicines — even when conventional supply pathways are disrupted or unavailable.


We are revisiting an earlier ProPG overview video that provides an insight into the foundations of our approach to pharmaceutical sourcing, access and supply. Since the video was produced, ProPG has continued to expand its capabilities and international supply network across Australia and Europe.


Watch the Feature


Key Capabilities


Critical Medicine Shortages


ProPG supports Australian hospitals and healthcare providers when registered medicines are unavailable or in shortage by sourcing suitable overseas-approved alternatives and supporting supply through pathways including the TGA Special Access Scheme (SAS) and Section 19A. Learn more about our unlicensed medicine supply pathways for Australian hospitals.


Regulatory Navigation & Compliance


Pharmaceutical access requires more than simply locating stock. ProPG supports supply within applicable regulatory and quality frameworks, with particular expertise in Australian special access and medicine shortage pathways.


Our focus is on maintaining product integrity, documentation, traceability and regulatory compliance throughout the supply chain.


Global Comparator & Clinical Trial Sourcing


ProPG supports pharmaceutical companies, CROs, CDMOs and clinical research partners with the sourcing of comparator medicines, reference listed drugs (RLDs) and clinical trial supplies from verified supply chains across Australia, Europe and international markets.


Pharmaceutical Supply Chain Infrastructure


Reliable pharmaceutical sourcing depends on the infrastructure behind it.


ProPG combines international sourcing capabilities with GDP-aligned pharmaceutical logistics, temperature-controlled transportation, qualified warehousing and established supply networks to manage complex pharmaceutical movements across markets.


Built for Complex Pharmaceutical Supply


Medicine shortages, special access requirements and clinical development programs often require solutions outside conventional pharmaceutical distribution channels. It's why hospitals and clinical trials need a strategic supply partner, not just a distributor.


ProPG brings together regulatory understanding, pharmaceutical sourcing expertise and international supply-chain infrastructure to help healthcare and pharmaceutical partners navigate these situations.


As we continue to strengthen our Australian operations and expand our European presence, our focus remains the same: accelerating access to medicines through reliable, compliant and transparent pharmaceutical supply.


To discuss a medicine shortage, special access requirement, comparator/RLD sourcing or clinical trial supply requirement, contact the Pro Pharmaceuticals Group team at info@propg.com.au or 1300 077 674. You can also speak with our team directly.



Recent Posts
Archive
Search By Tags
Follow Us
  • Twitter Social Icon
  • Google+ Basic Square

Legal & Trademark Notice
© 2026 Pro Pharmaceuticals Group Pty Ltd. All rights reserved.
Pro PG, CheckMed, and their respective logos are registered trademarks owned worldwide by Pro Pharmaceuticals Group Pty Ltd.
Pro Pharmaceuticals Group operates globally through associated entities, including CTS Pharmaceuticals Pty Ltd (Australia), Jemstar Sp. z o.o. (Poland), and Pro Pharmaceuticals Group NZ Ltd (New Zealand).

International Tax Registrations:
ABN 20 605 457 430 (Australia) | VAT DE401757398 (EU VAT ID) | Steuernummer 15/460/00493 (Germany) | VAT PL5263362401 (Poland) | VAT NL825524295B01 (Netherlands).

bottom of page